RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
THE ONCOLOGIST
Collezione AOU San Luigi di Orbassano

Items : 12

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape. in The oncologist / Oncologist. 2023 May 8;28(5):402-413. doi: 10.1093/oncolo/oyac264.

2023
AOU San Luigi di Orbassano

Novello S; Califano R; Reinmuth N; Tamma A; Puri T;

International Survey on Frailty Assessment in Patients with Cancer. in The oncologist / Oncologist. 2022 Oct 1;27(10):e796-e803. doi: 10.1093/oncolo/oyac133.

2022
AOU San Luigi di Orbassano

Banna GL; Cantale O; Haydock MM; Battisti NML; Bambury K; Musolino N; O'Carroll E; Maltese G; Garetto L; Addeo A; Gomes F;

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. in The oncologist / Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.

2022
AOU San Luigi di Orbassano

Mehra N; Fizazi K; de Bono JS; Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV;

Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study. in The oncologist / Oncologist. 2021 Oct;26(10):e1854-e1861. doi: 10.1002/onco.13851. Epub 2021 Jun 18.

2021
AOU San Luigi di Orbassano

Celio L; Cortinovis D; Cogoni AA; Cavanna L; Martelli O; Carnio S; Collovà E; Bertolini F; Petrelli F; Cassano A; Chiari R; Zanelli F; Pisconti S; Vittimberga I; Letizia A; Misino A; Gernone A; Bonizzoni E; Pilotto S; De Placido S; Bria E;

NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer. in The oncologist / Oncologist. 2018 Oct;23(10):1133-e112. doi: 10.1634/theoncologist.2018-0292. Epub 2018 Aug 3.

2018
AOU San Luigi di Orbassano

Gregorc V; Cavina R; Novello S; Grossi F; Lazzari C; Capelletto E; Genova C; Salini G; Lambiase A; Santoro A;

Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.

2014
AOU San Luigi di Orbassano

Panzuto F; Rinzivillo M; Fazio N; de Braud F; Luppi G; Zatelli MC; Lugli F; Tomassetti P; Riccardi F; Nuzzo C; Brizzi MP; Faggiano A; Zaniboni A; Nobili E; Pastorelli D; Cascinu S; Merlano M; Chiara S; Antonuzzo L; Funaioli C; Spada F; Pusceddu S; Fontana A; Ambrosio MR; Cassano A; Campana D; Cartenì G; Appetecchia M; Berruti A; et alii...

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.

2012
AOU San Luigi di Orbassano

Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.

2012
AOU San Luigi di Orbassano

Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.

2011
AOU San Luigi di Orbassano

Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;

Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer. in The oncologist / Oncologist. 2010;15(5):436-46. doi: 10.1634/theoncologist.2009-0225. Epub 2010 Apr 28.

2010
AOU San Luigi di Orbassano

Scagliotti G; Govindan R;

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. in The oncologist / Oncologist. 2009 Mar;14(3):253-63. doi: 10.1634/theoncologist.2008-0232. Epub 2009 Feb 16.

2009
AOU San Luigi di Orbassano

Scagliotti G; Hanna N; Fossella F; Sugarman K; Blatter J; Peterson P; Simms L; Shepherd FA;

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions. in The oncologist / Oncologist. 2008 Nov;13(11):1137-48. doi: 10.1634/theoncologist.2008-0162. Epub 2008 Nov 7.

2008
AOU San Luigi di Orbassano

Berruti A; Brizzi MP; Generali D; Ardine M; Dogliotti L; Bruzzi P; Bottini A;